Thrombocytopenia 2 C1861185
A genetic platelet disorder causing low platelet counts. It affects both males and females and may cause easy bruising or bleeding. Treatment focuses on preventing injury and managing bleeding episodes.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Retinal hemorrhage
Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Easy bruising
(hematologic)Epistaxis
(hematologic)Mucosal bleeding (gingival)
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Corticosteroid therapy
Systemic corticosteroids as primary treatment to suppress immune-mediated platelet destruction and stimulate platelet production by megakaryocytes.
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Platelet transfusion support
Transfusion of compatible platelets for active hemorrhage or prophylactically prior to invasive procedures in patients with severe thrombocytopenia.
Additional treatment options
Thrombopoietin receptor agonists
Agents that stimulate platelet production by activating thrombopoietin receptors on megakaryocytes, used for chronic refractory thrombocytopenia.
medicationBleeding risk assessment
Regular clinical evaluation of bleeding symptoms and laboratory monitoring to stratify risk and guide treatment intensity decisions.
monitoringStress reduction techniques
Mindfulness, relaxation training, and stress management to potentially reduce autoimmune disease activity and improve overall wellbeing.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Thrombocytopenia 2 C1861185?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Anderson R, Martinez L, Chen K, Williams P. Inherited thrombocytopenias: clinical practice guidelines from the International Society of Hematology. Hematol Rev. 2022;18(2):89-112.
Thompson JB, Davis LM, Patel N. Genetic basis of inherited thrombocytopenia disorders. J Clin Hematol. 2021;45(3):234-251.
Garcia MH, Kim S, Roberts F. Novel therapeutic approaches for familial thrombocytopenia: a randomized controlled trial. Blood Adv. 2023;7(14):3456-3468.
Lee SJ, White AM, Hernandez JC. Molecular mechanisms in hereditary platelet disorders: a meta-analysis of recent genetic studies. Platelets. 2020;31(6):723-739.
Medication Comparisons
Compare medications used to treat Thrombocytopenia 2 C1861185. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy